DEVELOPMENT OF NOVEL THERAPEUTIC NUTRIENT-BASED MEDICINES TO BE ADMINISTERED TO CANINES WHERE THE BASE CARRIER MATERIAL IS ALSO A NOVEL ENGINEERING DESIGNED TO DOUBLE AS A MASKING AGENT TO THE CANINE OLFACTORY AND TASTE SENSATION. STUDY OF PALATABILITY, COMPLIANCE PHARMACOLOGY AND FUNCTION OF WEIDER PET HEALTH CANINE THERAPEUTICS DESIGNED BY FRANCO CAVALERI BScNB
Clinical Research Division Biologic Nutrigenomic Health Research Corp.
688-2397 King George Hwy, BC V4A 7E9
Original post: September 9, 2010
Our challenges with palatability of nutrient-based canine and feline therapeutics have been ongoing since the inception of our program in 2004. Although we have been reasonably successful in the past to create products that facilitated compliance we are still challenged by the limitations created by dose or serving size. …..
Challenge: Determination of masking base system for new Weider Pet Formulation. The objective was to find a reasonable carrier for the functional ingredients of each therapy that could: 1) Mask the broad nutraceutical base without the use of MSG 2) Be different from the BiologicVET base system to maintain distinction between the two brands 3) Serve as pharmacological support for the functional ingredients 4) Support and carry inherently an extensive shelf life that may be required in the mainstream environment 5) Not cost-prohibitive in a channel where price will play a central role